Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closure

IND.173 - A phase I/II study of AZD0530 in combination with gemcitabine in patients with advanced pancreatic cancer - was officially closed to accrual on May 29, 2008.
http://www.ctg.queensu.ca/trials/ind/i173/173.html